Abstract P112 Table 1
HIV-infected (nā€Š=ā€Š44)HIV-uninfected (nā€Š=ā€Š122)
Mild or moderateSevereTotalMild or moderateSevereTotal
Any adverse event12 (27%)8 (18%)20 (45%)24 (20%)21 (17%)45 (37%)
Arthralgia7 (16%)4 (9%)11 (25%)17 (14%)6 (5%)23 (19%)
Rash8 (18%)0 (0%)8 (18%)9 (7%)0 (0%)9 (7%)
Symptomatic hepatitisNA5 (11%)5 (11%)NA10 (8%)10 (8%)
Anti-TB treatment interruption due to adverse eventNANA1 (2%)NANA10 (8%)